title: Rituximab monotherapy in relapsed lymphocyte-predominant Hodgkin's lymphoma.
abstract: Nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL) accounts for approximately 5% of Hodgkin's lymphoma, presents with early-stage disease and has an indolent course. Treatment is not well established. We present a patient diagnosed with NLPHL and treated with Rituximab second-line therapy after chemotherapy.
authors.affiliation: Servicio de Oncología Médica, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: Galán
authors.forename: Antonio C
authors.initials: AC
authors.lastname: Sánchez
authors.forename: Blanca
authors.initials: B
authors.lastname: Cantos
authors.forename: Mariano
authors.initials: M
authors.lastname: Provencio
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D005260:Female; D006689:Hodgkin Disease / Q000145:classification / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D012008:Recurrence; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab
references.citation: J Clin Oncol. 1999 Mar;17(3):776-83
references.pmid: 10071266
references.citation: Blood. 2006 Nov 15;108(10):3295-301
references.pmid: 16873669
references.citation: Blood. 2008 Jan 1;111(1):109-11
references.pmid: 17938252
references.citation: Blood. 2004 Nov 1;104(9):2675-81
references.pmid: 15231567
references.citation: Blood. 2003 Jan 15;101(2):420-4
references.pmid: 12509381
references.citation: Blood. 2003 Jun 1;101(11):4285-9
references.pmid: 12586628
references.citation: J Clin Oncol. 2002 Oct 15;20(20):4261-7
references.pmid: 12377971
references.citation: Eur J Haematol Suppl. 2005 Jul;(66):106-10
references.pmid: 16007877
references.citation: Oncology. 2009;76(1):26-9
references.pmid: 19033694
references.citation: Curr Opin Oncol. 2009 Sep;21(5):397-400
references.pmid: 19606035
references.citation: Hematology Am Soc Hematol Educ Program. 2006;:266-72
references.pmid: 17124071